The Next Generation of
Cardiac Intelligence
AI-guided cardiac imaging designed to expand access, improve consistency, and support scalable cardiovascular care.
Filed
EchoVest is a wearable, AI-powered cardiac imaging platform that significantly reduces healthcare's dependency on specialized sonographers. Combining advanced robotic hardware, adaptive acoustics, and a proprietary AI diagnostic engine, EchoVest delivers ICAEL-quality echocardiography with minimal operator dependency. The company has filed FDA 510(k) K254143 and a USPTO patent application. Raising $6M seed round; full terms available in offering materials to qualified investors.
Investment Highlights
The Structural Crisis
Why Now
Healthcare is entering a convergence point
AI Maturity
AI has reached real-time medical inference capability — designed to enable advanced clinical decision support at scale.
Rising Demand
Cardiovascular demand rising globally. Critical sonographer shortages are limiting access to essential diagnostics.
Point-of-Care Shift
Point-of-care diagnostics are becoming the standard of care, decentralizing imaging away from hospital radiology departments.
Market Validation
Butterfly Network and GE Healthcare validated the market — but remain entirely operator-dependent. EchoVest is designed to address that constraint.
"EchoVest is designed to dramatically reduce operator dependency."
Technology Stack
A Symbiotic System of Hardware and AI
Hardware Layer
- Wearable multi-probe system
- Precision robotic probe positioning
- Integrated probe architecture
- Multi-axis precision per probe
- High-precision positioning
Control Layer
- Real-time actuation via embedded controllers
- Sensor-driven positioning and safety logic
- Adaptive multi-frequency optimization
AI Layer
- AI-powered image acquisition guidance
- Automated interpretation and clinical workflow
- Future: Advanced image authentication
- High-accuracy ejection fraction measurement
- 70% reduction in interpretation time
Data Layer
- 15+ years of clinical cardiovascular data
- Cardiologist-confirmed imaging
- Structured for AI training and validation
Competitive Matrix
| Feature | EchoVest | Butterfly iQ | Caption Health | GE / Philips |
|---|---|---|---|---|
| Wearable | ✓ Yes | ✗ No | N/A | ✗ No |
| Multi-probe | ✓ Yes | ✗ No | N/A | ✓ Yes |
| AI Guidance | ✓ Yes | Limited | ✓ Yes | Limited |
| Robotic Positioning | ✓ Yes | ✗ No | ✗ No | ✗ No |
| Advanced Data Security | ✓ Yes | ✗ No | ✗ No | ✗ No |
| Autonomous Operation | ✓ Yes | ✗ No | Partial | ✗ No |
Strategic Moats
Integrated Hardware-Software Patent
Full-stack IP protection across hardware and AI software layers
Regulatory Lock-in
ICAEL protocol automation creates a powerful regulatory moat
First-Mover Advantage
5+ year head start — no direct competitor offering comparable operator-independent workflow
The Data Advantage
EchoVest is not just a device. It is a data-driven platform.
Data Accumulation Over Time
"This dataset enables faster model training, higher accuracy in real-world conditions, and a defensible competitive advantage. Competitors cannot easily replicate this foundation."
$9 Billion U.S. Cardiac Imaging Market
Click a segment to learn more
Large health systems with high-volume echo labs. Primary beachhead market with established reimbursement pathways (CPT 93306 at ~$380/study).
Cardiology offices and multi-specialty clinics. High growth potential as EchoVest is designed to enable cardiac imaging without a dedicated sonographer on staff.
Fastest growing segment. Remote patient monitoring and virtual care integration — EchoVest uniquely enables fully remote cardiac imaging.
Pre-participation cardiac screening for athletes. FDA clearance enables non-hospital cardiac assessment in field environments.
Military, government health agencies, and international markets including Saudi Arabia Vision 2030 deployment potential.
Market Convergence — Three Growth Vectors
EchoVest sits at the intersection of three accelerating markets
Revenue Architecture
Revenue Streams
Full-service device lease with maintenance, updates, and support included.
AI diagnostic platform, cloud storage, reporting, and analytics dashboard.
Transaction fee per completed autonomous echo study — aligned incentives.
Capital purchase for enterprise accounts and large health systems.
5-Year Financial Projections
Revenue vs. EBITDA (2026–2030)
$6M Seed Round Allocation
Deployment Curve (Units)
2025 Sprint Milestones
Regulatory Pathway
Leadership Team
Enayatullah Motahedy
- 20+ years clinical echocardiography experience
- Inventor — hardware + AI diagnostic system
- FDA 510(k) and USPTO patent filer
- RDCS certified
Dr. Azita Moalemi, MD, FACC
- Board-certified cardiologist
- Amelia Heart & Vascular Center
- ICAEL credentialing expert
- FACC — Fellow, American College of Cardiology
Strategic Partners
Saudi Arabia — Strategic Expansion Brief
EchoVest as National-Scale Cardiac Infrastructure for Vision 2030
A Cardiovascular Crisis Requiring Advanced Solutions
Saudi Arabia faces one of the world’s highest cardiovascular disease burdens. Vision 2030 targets reducing CVD mortality by 30% and expanding primary care access to 95% of citizens. EchoVest is designed to enable scalable cardiac screening — significantly reducing dependency on specialist labor.
Aligned with Saudi Digital Health Strategy
KSA’s digital health agenda prioritizes AI-first diagnostics, cloud-native platforms, and interoperable health records. EchoVest is natively designed for this architecture — AI-powered diagnostic engine, cloud reporting, and EMR integration. SFDA registration accelerated by FDA 510(k) predicate, enabling market entry as early as 2027.
Phased National Deployment
Enabling National Workforce Independence
Saudi Arabia faces the same global sonographer shortage magnified by Saudization requirements. EchoVest significantly reduces dependency on specialized sonographer staffing, enabling Saudi nationals to operate advanced cardiac imaging with minimal training. This directly supports Vision 2030 workforce localization mandates.
The Hajj Health Opportunity + National Infrastructure
2M+ annual Hajj pilgrims undergo extreme heat and physical exertion, creating elevated cardiac risk at unprecedented scale. EchoVest is designed to enable large-scale cardiac screening during Hajj at Mina/Arafat — a deployment scenario no existing device can match. Beyond Hajj, a national cardiac imaging network positions EchoVest as foundational health infrastructure across 13 KSA regions.
EchoVest in Action
See how AI-guided cardiac imaging works
Vest Application
Multi-probe wearable positioned on patient's chest. The EchoVest automatically detects placement and activates the probe array. Minimal operator positioning required.
AI Probe Positioning
AI-guided robotic actuators find optimal acoustic windows autonomously. Robotic actuators micro-adjust each probe in real-time for maximum signal quality.
Image Acquisition
Autonomous image capture — minimal operator intervention. Adaptive frequency probes capture complete cardiac anatomy across all standard views.
AI Analysis
Proprietary AI pipeline delivers instant interpretation. EchoVest achieves cardiologist-level accuracy in ejection fraction measurements — significantly reducing interpretation time.
Report Generated
Complete diagnostic report in under 90 seconds. Fully structured, cardiologist-ready echocardiogram report — minimal human intervention required throughout the workflow.
Use of Funds
"EchoVest represents a shift from manual imaging to intelligent acquisition. We are building a hardware platform, an AI system, and a data-driven ecosystem. This is not just a device — this is infrastructure for the future of cardiac diagnostics."